We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMB icon
3301
Limbach Holdings
LMB
$536M
$41K ﹤0.01%
+3,358
New +$36K
LRMR icon
3302
Larimar Therapeutics
LRMR
$454M
$41K ﹤0.01%
1,935
-1,948
-50% -$39K
MLPX icon
3303
Global X MLP & Energy Infrastructure ETF
MLPX
$3.56B
$41K ﹤0.01%
+1,536
New +$39K
PRDO icon
3304
Perdoceo Education
PRDO
$1.96B
$41K ﹤0.01%
3,238
-66,298
-95% -$797K
PRTA icon
3305
Prothena Corp
PRTA
$466M
$41K ﹤0.01%
3,381
-9,177
-73% -$109K
PSL icon
3306
Invesco Dorsey Wright Consumer Staples Momentum ETF
PSL
$84.1M
$41K ﹤0.01%
472
-1,182
-71% -$97.5K
QGEN icon
3307
Qiagen
QGEN
$8.93B
$41K ﹤0.01%
734
-1,227
-63% -$65.5K
SGU icon
3308
Star Group
SGU
$417M
$41K ﹤0.01%
4,374
+4,291
+5,170% +$41.2K
XOP icon
3309
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.69B
$41K ﹤0.01%
697
-20,982
-97% -$1.06M
QTTB icon
3310
Q32 Bio
QTTB
$458M
$41K ﹤0.01%
201
-1,331
-87% -$257K
PVLA
3311
Palvella Therapeutics
PVLA
$2.23B
$41K ﹤0.01%
203
-528
-72% -$110K
EVLO
3312
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$41K ﹤0.01%
171
-668
-80% -$82.6K
OSH
3313
DELISTED
Oak Street Health, Inc.
OSH
$41K ﹤0.01%
677
+78
+13% +$4.09K
KDMN
3314
DELISTED
Kadmon Holdings, Inc.
KDMN
$41K ﹤0.01%
9,977
-290,567
-97% -$1.15M
STLC
3315
DELISTED
iShares Factors US Blend Style ETF
STLC
$41K ﹤0.01%
1,154
-45,222
-98% -$1.5M
LMNX
3316
DELISTED
Luminex Corp
LMNX
$41K ﹤0.01%
1,753
-14,163
-89% -$329K
RLH
3317
DELISTED
Red Lions Hotel Corporation
RLH
$41K ﹤0.01%
11,857
+11,749
+10,879% +$26.4K
AGS
3318
DELISTED
PlayAGS
AGS
$40K ﹤0.01%
5,488
-42,988
-89% -$196K
ELDN icon
3319
Eledon Pharmaceuticals
ELDN
$291M
$40K ﹤0.01%
2,598
+1,341
+107% +$25.6K
FISI icon
3320
Financial Institutions
FISI
$825M
$40K ﹤0.01%
1,756
-14,687
-89% -$285K
IYH icon
3321
iShares US Healthcare ETF
IYH
$3.77B
$40K ﹤0.01%
805
-47,845
-98% -$2.26M
KOS icon
3322
Kosmos Energy
KOS
$1.51B
$40K ﹤0.01%
17,153
-487,801
-97% -$772K
LBRDA icon
3323
Liberty Broadband Class A
LBRDA
$5.07B
$40K ﹤0.01%
256
-561
-69% -$84.6K
MYGN icon
3324
Myriad Genetics
MYGN
$309M
$40K ﹤0.01%
2,020
-1,541
-43% -$24.9K
SPOK icon
3325
Spok Holdings
SPOK
$230M
$40K ﹤0.01%
3,646
-15,591
-81% -$154K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.